Tryp Therapeutics Inc. reported earnings results for the full year ended August 31, 2023. For the full year, the company reported net loss was CAD 5.27 million compared to CAD 7.49 million a year ago.
Tryp Therapeutics Inc. Canadian Securities Exchange
Equities
TRYP
CA89854F1062
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | 0.00% | +50.00% |
1st Jan change | Capi. | |
---|---|---|
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.17% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |